# FDA 483 - Eduardo Yanez Ruiz - January 22, 2026

Source: https://www.keypedia.com/records/483/eduardo-yanez-ruiz/cb3de10c-6f77-47a6-a632-b0a5d724c819

> FDA 483 for Eduardo Yanez Ruiz on January 22, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Eduardo Yanez Ruiz
- Inspection Date: 2026-01-22
- Product Type: drugs
- Office Name: Office of Inspections and Investigations
- Summary: An FDA inspection of Eduardo Patricio Yanez Ruiz, MD, a clinical investigator in Temuco, Chile, revealed a significant failure to conduct investigations according to the signed statement of investigator. Multiple subjects were improperly enrolled in two clinical studies, as they did not meet all inclusion criteria or met an exclusion criterion. This indicates a serious lapse in adherence to study protocols and patient eligibility.

## Related Documents

- [483 - 2026-01-22](https://www.keypedia.com/records/483/eduardo-yanez-ruiz/55ba9229-0141-4db0-b361-18baecc9d5e5)

## Related Officers

- [Gavin W. Pierce](https://www.keypedia.com/people/gavin-w-pierce/dfc6cdb8-2a63-42f4-8a19-6d394d16ee4d)

Company: https://www.keypedia.com/companies/eduardo-yanez-ruiz/366f1631-d34b-47e8-804b-a3d7d580d0e3

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8